This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Ford Global Technolgoies, LLC, Nanjing University of Chinese Medicine. Active years: 2019-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2019-2025
Title: Ming Zhao: Innovator in Anti-Cancer Compounds and Pipe Retaining Devices
Introduction
Ming Zhao is a notable inventor based in Nanjing, China. He has made significant contributions to the fields of medicinal chemistry and mechanical engineering. With a total of 2 patents, his work focuses on developing innovative solutions for health and industry.
Latest Patents
Ming Zhao's latest patents include a groundbreaking invention related to a (9β-H)-pimarane mother nucleus diterpenoid compound with anti-colon cancer activity. This invention discloses a preparation method and application of the compound, which has shown promising inhibition effects on colon cancer cells. Notably, one of the derivatives has demonstrated remarkable anti-proliferation effects on two colon cancer cell lines, HT-29 and SW620, surpassing the effects of the positive drug 5-fluorouracil. His second patent involves a pipe retaining device, which consists of a base panel, a clamping member with a flexible part, and an adjustable member that allows for selective engagement with retaining portions.
Career Highlights
Ming Zhao has worked with prominent organizations such as Ford Global Technologies, LLC and Nanjing University of Chinese Medicine. His experience in these institutions has contributed to his expertise in both the automotive and medical fields.
Collaborations
Ming has collaborated with notable coworkers, including Seven Qi and Lawrence Wu, enhancing his research and development efforts.
Conclusion
Ming Zhao's innovative work in anti-cancer compounds and mechanical devices showcases his dedication to advancing technology and health solutions. His contributions are paving the way for future developments in these critical areas.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile